Neuraxis, Inc. (NRXS)vsRevolution Medicines Inc (RVMD)
NRXS
Neuraxis, Inc.
$5.74
+0.88%
HEALTHCARE · Cap: $74.84M
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Neuraxis, Inc. generates 616% more annual revenue ($5.32M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -144.4%. RVMD earns a higher WallStSmart Score of 24/100 (F).
NRXS
Avoid22
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-43.5%
Fair Value
$3.24
Current Price
$5.74
$2.50 premium
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 115.7% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
Trading at 10.6x book value
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : NRXS
The strongest argument for NRXS centers on Revenue Growth, Debt/Equity. Revenue growth of 115.7% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : NRXS
The primary concerns for NRXS are Price/Book, EPS Growth, Market Cap.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
NRXS profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
NRXS carries more volatility with a beta of 1.45 — expect wider price swings.
NRXS is growing revenue faster at 115.7% — sustainability is the question.
NRXS generates stronger free cash flow (-1M), providing more financial flexibility.
Bottom Line
RVMD scores higher overall (24/100 vs 22/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Neuraxis, Inc.
HEALTHCARE · BIOTECHNOLOGY · USA
NeurAxis, Inc. is a neuromodulation therapy device company in the United States. The company is headquartered in Versailles, Indiana.
Visit Website →Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?